Annual Accounts Receivable
$0.00
-$5.56 M-100.00%
31 December 2023
Summary:
SAB Biotherapeutics annual accounts receivable is currently $0.00, with the most recent change of -$5.56 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$20.57 million (-100.00%). SABS annual accounts receivable is now -100.00% below its all-time high of $20.57 million, reached on 31 December 2020.SABS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
SAB Biotherapeutics quarterly accounts receivable is not available.SABS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -100.0% | - |
3 y3 years | -100.0% | - |
5 y5 years | - | - |
SABS Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -100.0% | |||
5 y | 5 years | -100.0% | |||
alltime | all time | -100.0% |
SAB Biotherapeutics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2023 | - | $0.00(-100.0%) |
June 2023 | - | $364.10 K(-52.3%) |
Mar 2023 | - | $763.10 K(-86.3%) |
Dec 2022 | $5.56 M | $5.56 M(-57.1%) |
Sept 2022 | - | $12.94 M(+34.6%) |
Date | Annual | Quarterly |
---|---|---|
June 2022 | - | $9.61 M(-18.4%) |
Mar 2022 | - | $11.79 M(+47.1%) |
Dec 2021 | $8.01 M(-61.1%) | $8.01 M(-53.2%) |
June 2021 | - | $17.11 M(-16.8%) |
Dec 2020 | $20.57 M(+629.8%) | $20.57 M |
Dec 2019 | $2.82 M | - |
FAQ
- What is SAB Biotherapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual accounts receivable year-on-year change?
- What is the all time high quarterly accounts receivable for SAB Biotherapeutics?
What is SAB Biotherapeutics annual accounts receivable?
The current annual accounts receivable of SABS is $0.00
What is the all time high annual accounts receivable for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual accounts receivable is $20.57 M
What is SAB Biotherapeutics annual accounts receivable year-on-year change?
Over the past year, SABS annual accounts receivable has changed by -$5.56 M (-100.00%)
What is the all time high quarterly accounts receivable for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly accounts receivable is $20.57 M